Pharmatek is expanding its GMP facilities with three additional cGMP manufacturing suites, a new automated packaging line and further drug product and cold storage, increasing production capacity by 50%. The packaging line can produce batch sizes of 10,000 bottles per day and is designed to handle highly potent and cytotoxic compounds, control humidity between 20% and 60% RH, and includes client manufacturing viewing areas. The project is scheduled for completion in 4Q13.
"Matched with our recent equipment purchases, the addition of automated packaging and larger suites enables us to handle larger scale clinical trial material productions, providing a higher level of customer service," said Kevin Rosenthal, director of manufacturing at Pharmatek. "The ability to serve our clients longer, as they advance their compounds down the development pipeline, reduces their overall costs and time-to-clinic."
"This expansion plays an important role in our continuous efforts to meet our clients' needs and our ongoing efforts to broaden our manufacturing capabilities," said Tim Scott, president of Pharmatek. "As we move toward becoming a more fully integrated CMO at all phases of the development pipeline, we will continue to invest in new equipment and our facilities."